Clinical Trial Update: Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial assessing whether semaglutide alters the pharmacology of oral contraceptives in adults with type 2 diabetes; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Oral contraceptives (combined oral contraceptives)
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED